Medical Device Hydrogels
Carboxymethyl Cellulose Platform
New medical devices based on Carboxymethylcellulose Crosslinkata for tissue augmentation, constitute today one absolute innovation on the world market. The potential benefits in terms of costs, production, performance and development, will bring Crosslinkata to carboxymethyl cellulose compete with other medical absorbable devices on the market. Carboxymethyl cellulose, could become the new starting point for the development of new devices used in other applications for medical use.
Hyaluronic Acid Platform
Hyaluronic acid is currently the gold standard in the
context of implantable medical devices, which are used in specialized
areas of medicine. Bioitech is developing a procedure for the use of hyaluronic
acid crosslinkato in ophthalmological and aesthetic context.
Research for the Future focuses on physiological preparations that slow
down the degradation of hyaluronic acid by hyaluronidase, with the addition
of polymer retarders.
Finally, some studies are focused on finding those chemical changes that
can amplify Rheological characteristics that have decreed in the success
of hyaluronic acid.
Medical Device Components
Plunger Rods
Started the production of Plunger Rod for syringes used for dermal filler with the purpose of improving handling of Erelle ™.
Raw Materials
Crossyal™
In the final phase the study which allowed pulverize crosslinked hyaluronic acid with cross-linking degrees overlapping with those used for filler for aesthetic use.
Key Business Areas
Carboxymethyl Cellulose Platform
© 2012, BIOITECH S.r.l. All right reserved | C.F. e P.I. 10671701000 | Via Chiana, 87 00198 - Roma (Italy)
